Equity
€770,791 ▲ 18.4%
APOTHEEK JOOSEN has made a profit in every financial year since 2011.
APOTHEEK JOOSEN
Lifetime
15 annual accounts with figures on one time axisGross marginpeak €322,076 (2025)
€322,076▲ 12.5%
Resultpeak €119,733 (2025)
€119,733▲ 16.0%
Equitypeak €770,791 (2025)
€770,791▲ 18.4%
Debts
€105,076▼ 50.7%
Staffpeak 2.2 FTE (2016)
2.1 FTEunchanged
Board1 name since 2010
1 directorChristine Joosen
Documentsfilings and deeds
29-07-20262 days before the deadline
2025abbreviated format
Gross margin from €286,303 to €322,076Equity from €651,059 to €770,791Debts from €213,183 to €105,076
Key points
from the 2025 annual accountsTurnover
≈ €1.2m estimated
The abbreviated format states no turnover.
Staff
2 employees on 31-12-2025
In 2025, 1 person joined and 0 left.
Liquidity
8.38 was 4.06 in 2024
Short-term debts fell from €206,623 to €101,104.
Filings
15 annual accounts since 2011
The last five annual accounts were filed 2 to 30 days before the end of the period.
Position in the sector
88.0%
Higher solvency than 93% of companies in retail trade. Sector median 36.6% · 12,836 companies.
Checked score
98
Excellent
Financially stronger than 85% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,273 companies (NACE 47, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025highest value
08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Liquidity: current ratio 8.38, cash €512,090
Equity €770,791 (88.0% of total assets)
Founded in 2010
Figures for financial year 2025 (filed on 29-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 97% on liquidity, 80% on profitability and 71% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as APOTHEEK JOOSEN has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of APOTHEEK JOOSEN itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for APOTHEEK JOOSEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.38 (4.06 in 2024), above the usual 1.5. Short-term debt is 11.5% and cash 58.5% of total assets. 12% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 days early
2024
23 days early
2023
26 days early
2022
28 days early
2021
30 days early
2020
29 days early
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 20 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0831884965
Appointment: Christine Joosen (director)
Gazette deed
Incorporation
published on 24-12-2010 · Gazette deed
First establishment
Kaakstraat 1, Wommelgem
Comparable companies
same main activity, similar in size and age| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| APOTHEEK JOOSEN Wommelgem | €875,867 | €322,076 | 88.0% | 2.1 |
| Apotheek De Stoop Deinze Deinze | €837,549 | €347,612 | 62.5% | 2.1 |
| APOTHEEK L. DE BOLLE Ninove | €802,923 | €334,854 | 88.6% | 2.2 |
| Apotheek Soetkin Op De Beeck Blankenberge | €916,196 | €338,847 | 36.8% | 1.8 |
| Sego Pharma Dessel | €939,072 | €397,420 | 63.7% | 1.7 |
| APOTHEEK ROEL VERELST Herentals | €997,677 | €320,633 | 41.2% | 1.6 |
| Apotheek De Hei Berlaar | €792,673 | €305,538 | 41.7% | 1.7 |
These companies have the same main activity as APOTHEEK JOOSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €793,000 and €998,000, founded between 2007 and 2012.
Official details
Source: KBO- Status
- Active since 01-12-2010Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.233.107.9672160 Wommelgem, since 01-12-2010
- Financial year end
- 31 December
- Peppol
- Reachable since 14-11-2025
Annual accounts 2025
- Total assets
- €875,867▲ 1.3%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 29-07-2026, 2 days before the end of the filing period
Insights on APOTHEEK JOOSEN
APOTHEEK JOOSEN files the abbreviated format. That format states no turnover. The gross margin rose from €230,789 in 2011 to €322,076 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK JOOSEN
- What is the company number of APOTHEEK JOOSEN?
- The company number of APOTHEEK JOOSEN is 0831.884.965. The VAT number is the same number with BE in front: BE 0831.884.965.
- Where is APOTHEEK JOOSEN based?
- The registered office is at Kaakstraat 1, 2160 Wommelgem.Company details
- What does APOTHEEK JOOSEN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK JOOSEN?
- APOTHEEK JOOSEN is a private limited company (BV).
- When was APOTHEEK JOOSEN founded?
- APOTHEEK JOOSEN was founded on 01-12-2010.
- Is APOTHEEK JOOSEN still active?
- Yes, APOTHEEK JOOSEN is an active enterprise in the KBO register.
- How many employees does APOTHEEK JOOSEN have?
- APOTHEEK JOOSEN had an average of 2.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK JOOSEN fall under?
- In its 2025 annual accounts, APOTHEEK JOOSEN states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK JOOSEN?
- The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €322,076 and 48 comparable companies (NACE 477). It probably lies between €880,000 and €1.9m.
- Is APOTHEEK JOOSEN profitable?
- In financial year 2025, APOTHEEK JOOSEN made a profit of €119,733.
- Where can I find the annual accounts of APOTHEEK JOOSEN?
- APOTHEEK JOOSEN filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK JOOSEN due?
- APOTHEEK JOOSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.